Skip to main content

Table 4 Number of days missing from work in the previous year at baseline and one year after start of treatment.

From: Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis

 

Baseline

After 12 Months

 

N

%

N

%

No

76

26.1%

148

50.9%

≤ 5 days

26

8.9%

27

9.3%

6–10 days

39

13.4%

14

4.8%

11–20 days

32

11.0%

8

2.8%

> 20 days

50

17.2%

18

6.2%

Not in employment

68

23.4%

62

21.3%

Missing information

0

0%

14

4.8%